TGTX Kronos AI forecast
A 30-trading-day price forecast for TG Therapeutics Inc. (TGTX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts TG Therapeutics Inc. at $52.93 on 2026-12-08, −6.2% from the last close of $56.44 on 2026-10-27. Eight out of ten sampled paths end between $47.88 and $56.41, and 1 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of TGTX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $57.12 | $54.01 | $58.07 |
| 2026-11-10 | $54.48 | $52.54 | $59.32 |
| 2026-11-17 | $53.27 | $49.16 | $57.19 |
| 2026-11-24 | $53.21 | $48.38 | $55.73 |
| 2026-12-01 | $53.70 | $48.44 | $55.36 |
| 2026-12-08 | $52.93 | $47.88 | $56.41 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for TGTX?
- Kronos AI's median forecast for TGTX is $52.93 in 30 trading days, −6.2% from the last close, with a 10–90% range of $47.88 to $56.41.
- Is the TGTX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC